article thumbnail

Biotech is Back to Work: JPM 2023 Week Wrap Up

LaVoie Health Science Blog

JP Morgan Week wrapped up earlier this month with a flurry of new data, partnerships, investor meetings, and pharmaceutical interest. While the overall economy is influencing the industry, a continued emphasis on value-based care will push the biotech sector through these uncertain times.

Biotech 98